About one-third of psoriasis sufferers develop psoriatic arthritis, with swelling, tenderness and pain in joints, affecting daily activities and lifestyle. Psoriatic arthritis (PsA) is a chronic ...

Celltrion's FDA approval of Steqeyma enhances pediatric psoriasis treatment, offering flexible dosing options for children ...

If you feel your psoriasis treatment is not producing what you seek here are 10 key factors that might be hindering your ...

Doctors explain how conditions like psoriasis, type 1 diabetes, and inflammatory bowel disease impact men, plus how these ...

To evaluate this, the authors systematically reviewed 14 studies involving a total of 169 patients (mean age 46.8 years), 74% ...

The BIO International Convention provides an ideal platform to showcase how FibroBiologics is potentially transforming the treatment landscape for chronic diseases,” said Pete O’Heeron. “With our ...

Celltrion, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new presentation of STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), in a ...

Icotrokinra was safe and effective for improving skin clearance among patients with at least moderate psoriasis in ...

Additionally, some infections may exacerbate or trigger psoriasis, such as strep throat. Regardless of whether you are on a biologic or immunosuppressive medication for psoriasis, it’s essential ...

The FamilyPso questionnaire revealed caregiver burden among partners and family members of patients with psoriasis, which ...

Chronic cough (CC) is common, predominantly affecting middle-aged females. Sufferers experience significantly impaired quality of life (QoL). Cough is associated with increased healthcare costs.